Cell fusion is essential for fertilization, myotube formation, and inflammation. Macrophages fuse under various circumstances, but the molecular signals involved in the distinct steps of their fusion are not fully characterized. Using null mice and derived cells, we show that the protease MT1-MMP is necessary for macrophage fusion during osteoclast and giant-cell formation in vitro and in vivo. Specifically, MT1-MMP is required for lamellipodia formation and for proper cell morphology and motility of bone marrow myeloid progenitors prior to membrane fusion. These functions of MT1-MMP do not depend on MT1-MMP catalytic activity or downstream pro-MMP-2 activation. Instead, MT1-MMP null cells show a decreased Rac1 activity and reduced membrane targeting of Rac1 and the adaptor protein p130Cas. Retroviral rescue experiments and protein binding assays delineate a signaling pathway in which MT1-MMP, via its cytosolic tail, contributes to macrophage migration and fusion by regulating Rac1 activity through an association with p130Cas.
INTRODUCTION
Cell fusion is fundamental in processes such as fertilization and vertebrate myogenesis (Chen et al., 2007) , and may also be important in inflammation (Johansson et al., 2008; Nygren et al., 2008) . Under certain circumstances, cells of the monocyte/macrophage lineage can fuse, giving rise to osteoclasts (OC) in bone or giant cells (GC) in inflamed soft tissues. These multinucleated derivatives acquire specialized functions in bone resorption and engulfment of pathogens and foreign bodies, respectively (Vignery, 2005) . Several diseases of the adult skeleton are related to disturbances in OC function, either through increased activity (bone metastasis, osteoporosis, Paget's disease) or decreased activity (osteopetrosis).
Molecules can contribute to cell fusion by either directly participating in membrane fusion or by affecting earlier steps in the process (Oren-Suissa and Podbilewicz, 2007; Primakoff and Myles, 2007) . The signaling pathways involved in cell-cell fusion have mostly been characterized in yeast and invertebrates; much less is known about the regulation of fusion by mammalian cells, and by macrophages in particular (Chen et al., 2007) . For example, EFF-1 and AFF-1 act as direct membrane fusogens during Caenorhabditis elegans development (Mohler et al., 2002; Sapir et al., 2007) , but the mechanisms by which proteins such as DC-STAMP, the d2 isoform v-ATPase, and CD200 contribute to macrophage fusion remain undefined (Cui et al., 2007; Lee et al., 2006; Yagi et al., 2005) . One central issue is how competent cells come into contact. In the case of myotubes, the myogenic precursors are already in close proximity, whereas sperm-egg fusion is dependent on sperm motility; however, the mechanisms by which OC and GC precursors achieve proximity are poorly understood.
MMPs (matrix metalloproteinases) are endopeptidases capable of degrading a variety of extracellular matrix components and of modulating the activity of several secreted and cellsurface proteins (Page-McCaw et al., 2007) . MT1-MMP (membrane type 1-MMP) is a membrane-anchored collagenase that plays important roles in pathophysiological settings, including the development of skeletal, lung, and adipose tissue, angiogenesis, and tumor invasion (Chun et al., 2006; Holmbeck et al., 1999; Oblander et al., 2005; Sabeh et al., 2004; Zhou et al., 2000) . Here we report that MT1-MMP, independent of its catalytic activity, regulates Rac1 signaling in myeloid cells, thereby contributing to their migration and fusion during osteoclastogenesis and GC formation in vitro and in vivo.
RESULTS

MT1-MMP Null Myeloid Cells Are Defective for OC Multinucleation In Vitro and In Vivo
MT1-MMP participates in leukocyte migration (Matias-Roman et al., 2005; Yang et al., 2006) , and we therefore analyzed hematopoietic development in MT1-MMP null mice. These mice die 2 weeks after birth, so 8-day-old mice were used for all analyses. Flow cytometry showed that the percentage of cells doubly positive for Mac-1 (macrophage-1 antigen; CD11b/ CD18; aMb2 integrin; CR3) dull and c-fms (CSF1R, colony-stimulating factor-1 receptor) was significantly higher in bone marrow (BM) from MT1-MMP null mice (2.5% ± 1.4% versus 1.3% ± 0.9%; p < 0.0324; n = 20). Because this population might be a common myeloid progenitor able to generate OC, and MT1-MMP null mice display bone defects, we explored this point further.
We exposed BM cultures to M-CSF (macrophage colonystimulating factor) and RANKL (receptor activator for nuclear factor-kB ligand). These conditions differentiate progenitors toward OC, giving rise to typical multinucleated cells expressing characteristic phenotypic markers, including tartrate-resistant acid phosphatase (TRAP) (Yagi et al., 2005) . The numbers of TRAP+ cells obtained from wild-type (WT) or MT1-MMP null BM progenitors were similar; however, MT1-MMP null progenitors generated fewer multinucleated TRAP+ cells (OC), and these were smaller and contained fewer nuclei ( Figure 1A ; see Figure S1 available online). No significant defects were found in multinucleated TRAP+ cells derived from heterozygous neonates (unpublished data). Similar results were obtained when MT1-MMP null sorted Mac-1+ BM cells were differentiated ( Figure 1B) , indicating a direct contribution of MT1-MMP in the progenitors, although a role from stroma in vivo cannot be ruled out.
The numbers of viable cells in cultures derived from WT or MT1-MMP null BM were similar ( Figure S2A ). Furthermore, WT and MT1-MMP null BM cells or derived OC showed similar relative mRNA expression of the OC genes PU.1, c-fms, RANK, TRAP, NFATc1, and calcitonin receptor ( Figure S2B ). This suggests that commitment and early differentiation of OC were not affected by the absence of MT1-MMP. Consistently, serum levels of TRAP, a measure of early commitment to the OC lineage, were similar in MT1-MMP null mice and control littermates (MT1-MMP +/+ 8.4 ± 2 U/l and MT1-MMP À/À 8.6 ± 5 U/l; n = 8).
These data indicate a requirement for MT1-MMP at later stages of OC differentiation. Accordingly, MT1-MMP mRNA expression was upregulated by day 4 of OC differentiation in WT cells ( Figure S3 ), coinciding with the reported initiation of cell fusion (Saginario et al., 1995) .
Retroviral reexpression of human MT1-MMP in deficient BM progenitors resulted in increased numbers of multinucleated TRAP+ cells (OC) (Figure 1C ), confirming the requirement for MT1-MMP. Moreover, a mixed culture of WT and MT1-MMP null progenitors rescued the multinucleation defect (% fusion = 5.5 for WT, 2.6 for null, and 5.5 for mixed) and showed that WT progenitors can fuse with deficient ones ( Figure S4 ); these data indicate that the presence of MT1-MMP in one partner allows efficient multinucleation.
To directly assess the impact of MT1-MMP deficiency on OC multinucleation in vivo, we analyzed TRAP expression in sections of femur and tibia from 8-day-old MT1-MMP null and WT mice ( Figure 1D , left). MT1-MMP null bones contained significantly fewer TRAP+ OC-like cells and a smaller relative TRAP+ area at the cartilage/bone interface ( Figure 1D , top right). The number of nuclei per TRAP+ cell at this interface was also significantly lower, confirming that decreased multinuclearity occurs in vivo ( Figure 1D , bottom right).
MT1-MMP Deficiency Results in Decreased OC Function In Vitro and In Vivo
Because multinucleation correlates with OC functionality (Chen et al., 2007) , we next tested the function of MT1-MMP null OC. Dentine resorption was significantly impaired in OC differentiated from MT1-MMP null BM progenitors ( Figure 1E ). These OC contained fewer nuclei than WT counterparts (unpublished data), indicating that the defect is matrix independent. Dentine resorption was rescued by reexpression of MT1-MMP in the null progenitors (mock = 2 3 10 5 and pR-MT1 = 6.3 3 10 5 mm 2 ; n = 3; p = 0.011).
To evaluate bone resorption in vivo, we measured serum levels of the C-terminal COL I telopeptide ICTP (Kiviranta et al., 2005) . Serum ICTP levels were significantly decreased in MT1-MMP null mice compared with WT ( Figure 1F) , showing that bone resorption by OC is less efficient in neonate MT1-MMP null mice.
MT1-MMP Is Required for Macrophage Fusion during GC Formation In Vitro and In Vivo
To evaluate the generality of the requirement for MT1-MMP in monocyte/macrophage fusion, we investigated the effect of MT1-MMP deficiency on GC formation. Formation of multinucleated GC in vitro was induced by stimulating BM progenitors with IL4 (Helming and Gordon, 2007) . The average number of nuclei per GC was significantly lower in multinucleated cells derived from progenitors from adult heterozygous mice or MT1-MMP null neonates (Figure 2A ).
Foreign-body reactions were induced in vivo by subcutaneous implantation of glass coverslips in WT and MT1-MMP heterozygous adult mice. Although the number of cells and fusion efficiency were similar on coverslips from the two genotypes, the average number of nuclei per GC was significantly lower in MT1-MMP heterozygous mice ( Figure 2B ), indicating a role of MT1-MMP in GC formation in vivo. These findings were confirmed in similar experiments performed with neonatal MT1-MMP-deficient mice, in which the formation of GC in response to a foreign body was almost abolished ( Figure 2C ).
MT1-MMP Null OC Progenitors Display Impaired
Chemotaxis, Motility, and Morphology Progenitors within the OC differentiation niche must come into contact in order to fuse. Chemotactic cues involved include the cytokine RANKL and the chemokine MCP-1/CCL2 (Henriksen et al., 2003; Kim et al., 2005) . We previously showed that MT1-MMP is involved in human monocyte migration toward MCP-1/CCL2 (Matias-Roman et al., 2005) . Here we analyzed the chemotactic response of mouse MT1-MMP null BM cells to RANKL across activated endothelial cell monolayers to model the BM stromal niche. Compared with WT counterparts, MT1-MMP null BM cells (total cells or the progenitor-rich Mac-1 dull subpopulation) showed significantly diminished endothelial transmigration in response to RANKL ( Figure 3A) .
The effect of MT1-MMP deficiency on the behavior of individual OC progenitors was next investigated by time-lapse microscopy of BM cells cultured in the presence of M-CSF and RANKL for 4 days, just before cell fusion starts (Movies S1 and S2). MT1-MMP null cells moved more slowly than WT ( Figure 3B , left), and whereas WT cells migrated in various directions over relatively long distances, MT1-MMP null cells mostly migrated over shorter distances, correlating with a to-and-fro movement pattern in the movies. Quantification of velocity and migrated distance showed that these differences were significant ( Figure 3B , right). Similar defects were observed with MT1-MMP-deficient Mac1+ BM cells ( Figure 3C ; Movies S3 and S4). We then explored whether this defect in progenitor migration could account for the defect in OC multinucleation by MT1-MMP null cells. The multinucleation efficiency of MT1-MMP null progenitors increased with increasing plating density but never matched that of WT, even when cells were plated in contact ( Figure 3D ). Detailed analysis of movies showed that MT1-MMP null cells had a weaker membrane protrusive activity. Accordingly, MT1-MMP null OC progenitors had a significantly smaller average adhesive area and a high elliptical factor (EF), an index of cellular elongation ( Figure 3E ). These findings demonstrate that MT1-MMP modulates not only the locomotion of BM OC progenitors but also other migration-associated parameters that contribute to fusion such as morphology, spreading, and lamellipodia formation. Equivalent phenotypes (decreased adhesive area and increased EF) were observed in similarly treated MT1-MMP-deficient Mac-1+ BM cells ( Figure 3F ).
MT1-MMP Catalytic Activity Is Not Essential for Its Regulation of Myeloid Cell Migration and Fusion
One of the main downstream targets of MT1-MMP is pro-MMP-2, which is activated by MT1-MMP-mediated proteolysis (Sato et al., 1994) . Genetic evidence indicates that MMP-2 is involved in bone biology (Martignetti et al., 2001; Mosig et al., 2007) , and we therefore investigated whether the lack of MMP-2 activation might contribute to the defects observed in MT1-MMP null cells. MMP-2 null neonate mice and derived cells did not differ from WT in the numbers of BM-derived TRAP+ OC in vitro or in the formation of GC in vivo ( Figures 4A and 4B ). Similarly, MMP-2 null BM myeloid progenitors showed no differences from WT equivalents in adhesive area, EF, or motility after culture with M-CSF and RANKL (Figures 4C and 4D) . Therefore, the phenotypes observed in MT1-MMP null myeloid progenitors appear to be unrelated to the lack of active MMP-2.
We directly assessed the requirement of MT1-MMP catalytic activity by reexpressing WT and catalytically inactive MT1-MMP in null myeloid progenitors. Retrovirally reexpressed wild-type MT1-MMP increased the adhesive area and membrane protrusive activity while decreasing the EF (Figure 4E) ; moreover, null cells with restored MT1-MMP expression also migrated at higher speed, over longer distances, and with more varied trajectories than mock-infected MT1-MMP null cells ( Figure 4F ; Movies S6 and S7). Remarkably, the adhesive area, EF, membrane protrusive activity, and motility phenotypes were similarly rescued by reexpression of a catalytically dead version of human MT1-MMP harboring the E240A mutation (Figures 4E and 4F; Movie S8) . Reexpression of the inactive MT1-MMP mutant also significantly increased OC formation ( Figure 4G ), confirming that catalytic activity is dispensable for the contribution of MT1-MMP to these events.
MT1-MMP Contributes to the Migration and Fusion of BM Myeloid Progenitors by Regulating Rac1 Activity
The small-GTPase Rac1 regulates macrophage cell spreading, membrane ruffling, morphology, and migration, and is implicated Figure 2C . Pictures show GC formation. The scale bar indicates 50 mm. The histogram shows arithmetic means ± SE of the number of GC per field (n = 4 for WT and n = 7 for null mice).
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(C) BM cells from WT and MMP-2 null mice were cultured and analyzed as in Figure 3E . The scale bars indicate 20 mm. Histograms show arithmetic means ± SE of average adhesive area and EF for WT and MMP-2 null BM OC progenitors. A total of 100 cells was analyzed for each genotype (n = 5 for WT and n = 13 for null mice).
(D) BM cells from WT and MMP-2 null mice were cultured and analyzed as in Figure 3B . Histograms show arithmetic means ± SE of velocity and total distance traveled for WT and MMP-2 null BM OC progenitors. A total of 100 cells was analyzed for each genotype (n = 5 for WT and n = 8 for null mice).
(E) BM progenitors from WT or MT1-MMP null mice were infected with retrovirus encoding human MT1-MMP (pR-MT1) or a catalytically inactive MT1-MMP mutant (pR-E240A) and cultured and analyzed as in Figure 3E . Histograms show arithmetic means ± SE of average adhesive area (top) and EF (bottom). A total of 200 cells was analyzed per genotype (n = 4 for WT and n = 6 for null mice).
(F) BM cells were infected as in (E), and analyzed as in Figure 3B . in distinct cell-fusion scenarios (Jay et al., 2007; Pajcini et al., 2008; Wang et al., 2008; Wells et al., 2004) . Rac1 activity and membrane targeting were significantly reduced in MT1-MMP null BM progenitors ( Figures 5A and 5B) . Accordingly, Rac1 nicely decorated the lamellipodia of WT progenitors, colocalizing with F-actin, in contrast to reduced Rac1 presence at these sites in MT1-MMP null cells ( Figure S5A ). This correlates with reduced numbers of focal complexes at the perimeter of MT1-MMP null progenitors ( Figure S5B ). Retroviral reexpression of MT1-MMP in null BM progenitors significantly increased Rac1 membrane targeting and activity ( Figures 5C and 5D ), demonstrating that MT1-MMP is required for proper Rac1 activity in these cells. Rac1 activity in null progenitors was also increased by reexpression of the inactive mutant MT1-MMPE240A, indicating that the catalytic activity of MT1-MMP is dispensable for its regulation of Rac1 ( Figure 5D ).
To assess whether this impaired Rac1 activity contributed to the observed migration and fusion defects, we expressed constitutively active Rac1 (Guo and Zheng, 2004) in MT1-MMP null myeloid progenitors. Retroviral expression of active Rac1 in MT1-MMP null cells replicated the effects of MT1-MMP reexpression on cell spreading, morphology, membrane protrusive activity, and motility ( Figures 5E and 5F) ; accordingly, active Rac1 expression rescued the OC multinucleation defect of MT1-MMP null progenitors ( Figure 5G ).
Association of the MT1-MMP Cytosolic Tail with p130Cas Is Involved in Its Regulation of Cell Morphology, Motility, and Fusion in Myeloid Progenitors
MT1-MMP can interact with the focal adhesion protein p130Crk-associated substrate (CAS) in endothelial cells (Gingras et al., 2008) , and the p130Cas-Crk complex participates in Rac1 membrane targeting in certain cell types (Albert et al., 2000) . The amount of p130Cas in the membrane fraction was significantly decreased in MT1-MMP null progenitors ( Figure 6A ). In addition, colocalization of p130Cas with the leukocyte membrane marker MHCII was barely detectable by immunofluorescence in MT1-MMP null progenitors, whereas it was observed in WT cells ( Figure S6 ). Retroviral reexpression of MT1-MMP significantly increased the amount of p130Cas in the membrane fraction of null myeloid progenitors ( Figure 6B ). These data suggest that MT1-MMP is required for proper p130Cas localization at the cell membrane of these cells.
Pull-down assays in myeloid progenitors showed that p130Cas can bind the cytosolic domain of MT1-MMP; moreover, the mutant MT1-MMPY573F bound p130Cas less efficiently, showing that MT1-MMP Tyr 573 participates in the association ( Figure 6C ). Retroviral expression of MT1-MMPY573F did not rescue the OC multinucleation phenotype of MT1-MMP null cells ( Figure 6D ), indicating that interaction between MT1-MMP and p130Cas is required for this event.
The role of p130Cas in the phenotype of MT1-MMP null myeloid progenitors was analyzed by retroviral infection with p130Cas, which increases p130Cas expression in both the cytosolic and membrane fractions (unpublished data). Overexpression of p130Cas increased Rac1 activity in MT1-MMP null myeloid cells, suggesting that p130Cas is a key intermediate between MT1-MMP and Rac1 in these cells ( Figure 6E ). Consistently, p130Cas overexpression increased the adhesive area of MT1-MMP null cells and decreased their EF ( Figure 6F ), increased their velocity and migrated distance ( Figure 6G ), and rescued their OC multinucleation defect ( Figure 6H ), mimicking the effect of reexpressed MT1-MMP or active Rac1.
DISCUSSION
In this report we identify a new function of MT1-MMP, independent of its catalytic activity, in the formation of multinucleated OC and GC from myeloid progenitors. This function is mediated by regulation of Rac1 via a novel signaling pathway involving association of the MT1-MMP cytosolic tail with p130Cas. MT1-MMP thus regulates the morphology, motility, and fusion of BM myeloid progenitors.
Macrophage cell fusion occurs in distinct pathophysiological settings (Vignery, 2005) . CD44, CD47 and its ligand MFR/ SIRP1a, DC-STAMP, CD200, and the d2 isoform of v-ATPase are implicated in macrophage fusion, but the underlying molecular mechanisms are not well defined (Cui et al., 2006 (Cui et al., , 2007 Lee et al., 2006; Yagi et al., 2005) . Within the metzincin protease superfamily, members of the ADAM subfamily were suggested to participate in cell-fusion events, although this remains controversial (Primakoff and Myles, 2007) , and MMP-9 participates in GC formation (Maclauchlan et al., 2009 ). The demonstration that MT1-MMP contributes to macrophage multinucleation in distinct cell contexts identifies a novel participant in this process and a new function for this protein.
The physiological relevance of these findings is highlighted by the decreased bone resorption in newborn MT1-MMP null mice, as indicated by lower amounts of serum ICTP. However, this impaired OC function does not result in increased bone mass, in contrast to other mouse models of defective OC fusion such as DC-STAMP and d2 v-ATPase null mice (Lee et al., 2006; Yagi et al., 2005) . Osteoblast function is also compromised in MT1-MMP null mice, and this might contribute to the complex bone phenotype observed, possibly suggesting a dual role for MT1-MMP in bone development with actions in OC-mediated bone resorption and also in osteoblast bone deposition. It will be interesting to dissect this dual role in the future by conditional MT1-MMP deletion in OC and osteoblasts, once a floxed allele is available. Furthermore, the drastic reduction of GC formation in MT1-MMP null neonates and the impairment of this process in heterozygotes suggest that a minimum amount of MT1-MMP is required for an effective inflammatory response to foreign bodies, reinforcing the importance of MT1-MMP in this inflammatory situation. Hence, cell-type-specific modulation of macrophage MT1-MMP might have potential in the treatment of disorders involving either increased OC-mediated bone resorption (such as osteoporosis and bone metastasis) or chronic formation of GC (such as granulomatous disease). Whether MT1-MMP participates in heterotypic fusion events relevant to inflammation also deserves further work (Johansson et al., 2008; Nygren et al., 2008) .
Cell fusion is a complex process in which several sequential steps must be finely orchestrated. It is unlikely that MT1-MMP acts as a direct fusogen (Oren-Suissa and Podbilewicz, 2007) , and we therefore explored alternative mechanisms by which MT1-MMP might contribute to macrophage fusion, such as the Developmental Cell The histogram shows the average fold induction ± SE of active Rac1 quantified by densitometric analysis (n = 3 independent experiments from 9 mice). (E) BM progenitors were infected with retrovirus encoding constitutively active Rac1 (pM-Rac1) and cultured as in (A). Morphological parameters were analyzed as in Figure 3E . The scale bar indicates 20 mm. Data are arithmetic means ± SE. A total of 100 cells was analyzed per genotype (n = 4).
(F) Motility parameters for BM cells infected with pM-Rac1 were measured as in Figure 3B for at least 100 cells per genotype (n = 4). Data are arithmetic means ± SE. modulation of membrane receptors. MT1-MMP can process the hyaluronan receptor CD44, which has diverse roles in OC development and macrophage fusion (Cui et al., 2006; de Vries et al., 2005; Kajita et al., 2001 ). However, we found no link between impaired CD44 shedding in the absence of MT1-MMP and the multinucleation defect (unpublished data). MT1-MMP participates in human monocyte migration and transmigration (Matias-Roman et al., 2005) , and efficient migration is required for proper macrophage fusion. Our data showing defective chemotaxis and motility of MT1-MMP null BM cells and the partial rescue of the multinucleation phenotype in highdensity cultures indicate that impaired locomotion contributes to the fusion defect in the absence of MT1-MMP. However, the incomplete rescue even at high cell densities indicates that other MT1-MMP actions are involved, including regulation of cell spreading and lamellipodia formation, important events in the fusion process.
MT1-MMP is a pericellular collagenase also involved in the proteolytic activation of pro-MMP-2 (Sato et al., 1994) . Similar to its role in lung and submandibular gland development (Oblander et al., 2005) , the contribution of MT1-MMP to OC and GC formation was found to be independent of pro-MMP-2 activation because the absence of MMP-2 did not impair these processes or alter the morphology and motility of myeloid progenitors. More importantly, the demonstration that retroviral re-expression of an inactive MT1-MMP mutant rescues the morphology, motility, and fusion phenotypes of null progenitors provides convincing evidence in support of important pathophysiological functions of MT1-MMP unrelated to its proteolytic activity (Sakamoto and Seiki, 2009) .
Signaling pathways involved in cell-cell fusion have mainly been analyzed in mating yeast and myoblast fusion in Drosophila melanogaster. The Drosophila Duf-Ants-Mbc-Rac-Scar pathway and in mammals the guanine-nucleotide exchange factors (GEFs) Brag2 and Dock180 (Mbc mammalian homolog), which, respectively, act on ADP-ribosylation factor 6 (ARF6) and Rac1, are important for myoblast fusion (Chen et al., 2007; Pajcini et al., 2008) . The Dock180/Rac1 pathway also participates in the formation of multinucleated GC (Pajcini et al., 2008) . MT1-MMP is identified as an upstream regulator of Rac1 activity in BM progenitors that might act at a similar hierarchical level as Duf in Drosophila myoblast fusion. Our findings also support the participation of Rac1 in macrophage fusion during OC and GC formation in vivo. Rac1 might contribute to myeloid cell and myoblast fusion through distinct mechanisms; for example, Rac1 regulates migration and actin assembly in myeloid pre-OC but regulates postmigration events during myoblast fusion (Wang et al., 2008; Vasyutina et al., 2009 ). MT1-MMP null mice also display myoblast fusion defects and, therefore, similar to Rac1, the contribution of MT1-MMP may be different in these two distinct fusion scenarios (this report; Ohtake et al., 2006) . MT1-MMP acts as a positive regulator of Rac1 in primary BM progenitors, with Rac1 activity in MT1-MMP null OC progenitors less than 25% that in WT cells. This would place MT1-MMP null progenitors between stages I and II on the Pankov scale, with very low Rac activity and almost no migration (Pankov et al., 2005) . This low Rac1 activity might explain most of the phenotypes of MT1-MMP null progenitors, including small size, elongated morphology, low lamellipodia activity, and impaired migration (Wang et al., 2008; Wells et al., 2004) ; in fact, the low lamellipodia activity might contribute, together with impaired migration, to the defective cell fusion observed in the absence of MT1-MMP (Jay et al., 2007) . The chemotactic defects in BM cells might, however, be explained by impaired Cdc42 activity (Allen et al., 1998) , which was observed in MT1-MMP null progenitors (unpublished data). Rac1 might also regulate BM progenitor motility by modulating focal complex formation, consistent with the reduction in vinculin-positive structures at the lamellipodia of MT1-MMP null progenitors. This pattern might indicate an action of MT1-MMP in the recruitment of focal adhesion components or in the modulation of integrin binding or recycling at these sites. This idea is supported by the suggestion that MT1-MMP can participate in focal adhesion turnover (Takino et al., 2006) . In cell contexts in which Rac1 activity is deregulated or dispensable, it may be that the requirement of MT1-MMP for migration on 2D matrices can be circumvented (Sabeh et al., 2004) .
Rac1 activity can be regulated at the levels of GTP loading and cell-membrane targeting, and Rac1 membrane targeting is, in fact, reduced in the absence of MT1-MMP. The primary event triggering Rac1 membrane targeting is integrin binding to the extracellular matrix (del Pozo et al., 2002) . MT1-MMP can associate with avb3 and b1 integrins in distinct cell contexts, and MT1-MMP localizes to adhesion sites in response to integrin ligation through a Rab8-mediated mechanism (Bravo-Cordero et al., 2007; Galvez et al., 2002) . It is possible that MT1-MMP acts as an integrin coreceptor, modulating Rac1 targeting. Consistent with this, both MT1-MMP and Rac1 are localized at similar lipid-rich membrane microdomains (del Pozo et al., 2004; Galvez et al., 2004 ), but it is not known whether MT1-MMP influences integrin-mediated Rac1 targeting at these domains.
The independence of MT1-MMP-mediated Rac1 regulation from proteolytic activity indicates a mechanism not involving the extracellular catalytic domain. The p130Cas-Crk adaptor complex is another promoter of Rac1 membrane targeting (Cho and Klemke, 2002) , and the MT1-MMP cytosolic tail can interact with p130Cas in endothelial cells (Gingras et al., 2008) . Our data confirm the MT1-MMP-p130Cas interaction and show that MT1-MMP Tyr573, in the cytosolic tail, plays a role in this association. MT1-MMP participates in the recruitment of p130Cas to the myeloid progenitor cell membrane, as shown by the decrease in p130Cas membrane targeting in MT1-MMP null progenitors and the rescue of this targeting by reexpression of MT1-MMP in null cells. Because the p130Cas-Crk complex can act upstream of Cdc42 (Liu et al., 2007) , the altered membrane localization of p130Cas might also contribute to the GEFs; in this regard, the MT1-MMP cytosolic tail can interact with p27RF-Rho, a regulator of RhoA activation (Hoshino et al., 2009) .
Our results suggest a model in which MT1-MMP at the membrane of BM myeloid progenitors contributes to the efficient recruitment and activation of the p130Cas-Rac1 complex at lamellipodia (Figure 7) . Impairment of this signaling pathway in the absence of MT1-MMP would decrease lamellipodia activity and cell migration, resulting in inefficient cell fusion.
EXPERIMENTAL PROCEDURES Mice and Cells
Mmp14-deficient mice (MT1-MMP
À/À ) in the C57BL/6 background were generated as described (Zhou et al., 2000) . Mmp2-deficient mice (Itoh et al., 1997) were kindly provided by S.J. Weiss (University of Michigan, Ann Arbor). Mice were handled under pathogen-free conditions in accordance with institutional guidelines; the animal protocols were approved by the institutional committee. Experiments were performed with 8-day-old MT1-MMP À/À or WT littermates unless otherwise indicated. Single-cell suspensions were obtained from bone marrow (BM) and spleen; only data from BM cells are presented. Serum was obtained from peripheral blood incubated for 1 hr at 37 C.
Human umbilical vein endothelial cells were cultured as described (Galvez et al., 2002) .
Osteoclastogenesis and Dentine Resorption Assays OC were generated from BM or spleen progenitors. Cells were seeded at 1.5 3 10 5 per well in 96-well plates in triplicate and incubated in a-MEM supplemented with 10% FBS, 25 ng/ml M-CSF, and 25 ng/ml RANKL (PeproTech). After washing on day 3, M-CSF was decreased to 10 ng/ml and RANKL was kept at 25 ng/ml. Cultures were stained with tartrate-resistant acid phosphatase (TRAP; Sigma) on day 12. The percentage of fusion was calculated from the number of TRAP+ cells containing R3 nuclei with respect to the total number of TRAP+ cells. DiO and DiI probes were from Molecular Probes. Resorption was assayed by culturing progenitors on dentine plates (BioCoat, OAAS; BD Biosciences) for 16 days. Areas of dentine resorption were measured with Laserpix software.
Giant-Cell Formation GC formation in vivo was induced as described (Mariano and Spector, 1974) . Glass coverslips (5 or 12 mm diameter) were implanted subcutaneously in the backs of mice, and after 4 days the coverslips were removed and stained with hematoxylin and eosin (H&E). GC formation was also induced in vitro (Helming and Gordon, 2007) . BM progenitors were cultured in the presence of 25 ng/ml M-CSF. After 3 days, cells were plated at 1.5 3 10 5 cells/well in 96-well plates with 50 ng/ml IL4 (PeproTech) and cultured for a further 4 days. Cells were stained with H&E and Hoechst 33342 (Sigma). The number of nuclei per multinucleated cell was counted by two blinded observers; at least 20 cells were counted per condition.
GTPase Pull-Down Assay, Subcellular Fractionation, and Western Blot Analysis Rac1 activity was determined by GST-PBD (Pak1 p21-binding domain) pulldown assay as described (del Pozo et al., 2002) . Particulate and soluble fractions were obtained from cultured OC progenitors (del Pozo et al., 2002) , and equal protein amounts were analyzed by western blot; densitometry analysis was performed with Quantity One or ImageJ software. The percentage of Rac1 and the amount of p130Cas in the particulate fraction (normalized to b1 integrin levels) were calculated. Anti-Rac was from Upstate Biotechnology, and anti-p130Cas mAb was from Pharmingen.
Time-Lapse Microscopy Imaging BM cells were cultured with M-CSF and RANKL for 4 days, and phase-contrast images were collected with a Leica microscope with a 103 objective. Images were analyzed with MetaMorph software (Universal Imaging). To determine cell trajectories in phase-contrast image series (images captured at 15 min intervals over 16 hr), the centroids of the cell nuclei were tracked. Tracking analysis was quantified in 12 cells from n independent movies using the track object function.
Quantification of Cell Adhesive Area and Elliptical Factor F-actin-stained OC progenitors (after a 4 day culture with M-CSF and RANKL) were outlined using the Kirsch edge detection algorithm included in MetaMorph software. Outlines were checked and corrected by hand if necessary. Using MetaMorph's integrated morphometry analysis function, cell EF (length/breadth) was also determined as a measure of elongation.
(G) Cells were infected and cultured as in (E) and motility parameters were measured as in Figure 3B for at least 100 cells per genotype (n = 4). The histograms show arithmetic means ± SE of the velocity and total distance traveled under the different conditions (n = 4). MT1-MMP is expressed in BM myeloid progenitors and is required for optimal Rac1 activity in these cells. The functional impact of this regulation is underlined by the defects in morphology, motility, and cell fusion observed in the absence of MT1-MMP and that can be rescued by constitutively active Rac1. The role of MT1-MMP in this process does not require its catalytic activity. Instead, the MT1-MMP cytosolic tail can bind the adaptor protein p130Cas, and MT1-MMP Tyr573 seems to play a role in this association. p130Cas acts as an intermediate modulator of Rac1 activity in this setting because overexpression of p130Cas also rescues Rac1 activity and the multinucleation phenotype in MT1-MMP null progenitors.
Statistical Analysis
Data are shown as arithmetic means ± SE for the independent experiments performed for each condition determined with Prism 3.0 (GraphPad Software). Statistical differences among experimental groups were evaluated by Student's t test; differences were considered statistically significant at *p % 0.05, **p % 0.01, and ***p % 0.001.
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